Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Portfolio Pulse from Benzinga Newsdesk
Genetic Technologies has received a notification from Nasdaq regarding a minimum bid price deficiency. The company's stock, GENE, has been trading below the minimum $1.00 per share requirement for continued listing.
July 21, 2023 | 12:07 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Genetic Technologies' stock, GENE, is at risk of being delisted from Nasdaq due to trading below the minimum bid price requirement.
The Nasdaq notification indicates that GENE has been trading below the minimum bid price requirement. This puts the stock at risk of being delisted, which could negatively impact its liquidity and marketability, potentially leading to a further decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100